July 26, 2007 - St. Jude Medical Inc. announced that the U.S. FDA cleared the ACross Transseptal Access System, a device designed to improve control and simplify the procedure physicians use to access the left atrium during complex cardiac procedures such as atrial fibrillation ablation, in addition to receiving a Health Canada License.

July 25, 2007 – Multidetector computed tomography (MDCT) angiography is highly accurate in depicting intracranial aneurysms, according to a study published in the August issue of Radiology. In addition, MDCT angiography can be used to quickly determine the possibility of using minimally invasive treatment rather than open surgery.

July 25, 2007 – Using 64-slice coronary CT angiography as a diagnostic test poses a substantial risk of developing radiation-induced cancer for women and younger patients, according to a study published in the Journal of the American Medical Association earlier this month.

July 25, 2007 – According to a study published in the July 25 issue of JAMA, high-risk patients with hypertrophic cardiomyopathy (HCM) may reduce the risk of sudden cardiac death with an implantable cardioverter-defibrillator that terminates dangerous heart rhythm disorders.

The studies indicates that clinicians have been using implantable cardioverter-defibrillator (ICD) as a potentially life-saving treatment in high-risk patients with HCM, however, the effectiveness and appropriate selection of HCM patients for this therapy remains uncertain.

July 25, 2007 - St. Jude Medical, Inc. announced the first patient implant in its clinical trial of Trifecta, a new investigational stented, pericardial tissue heart valve, that will undergo a trial test its safety and efficacy as a replacement for the aortic valve.